` 2267 (Yakult Honsha Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

2267
vs
Nikkei 225

Over the past 12 months, has outperformed Nikkei 225, delivering a return of -3% compared to the Nikkei 225's 8% drop.

Stocks Performance
2267 vs Nikkei 225

Loading

Performance Gap
2267 vs Nikkei 225

Loading
2267
Nikkei 225
Difference

Performance By Year
2267 vs Nikkei 225

Loading
2267
Nikkei 225
Add Stock

Competitors Performance
Yakult Honsha Co Ltd vs Peers

Nikkei 225
2267
NESN
MDLZ
BN
KHC
Add Stock

Yakult Honsha Co Ltd
Glance View

Market Cap
1.1T JPY
Industry
Food Products

Yakult Honsha Co., Ltd., a company rooted in Japanese tradition and scientific innovation, has become a global powerhouse in the probiotics industry. The journey began in 1935 when microbiologist Minoru Shirota pioneered the development of a fermented milk drink containing a unique strain of bacteria, Lactobacillus casei Shirota. This visionary endeavor aimed to improve gut health utilizing the principles of preventive medicine, a novel concept at the time. Yakult's flagship product, a small, iconic bottle of sweet-tasting probiotic milk, swiftly captured the attention and trust of Japanese consumers, setting the company on a trajectory of continuous growth and worldwide expansion. The company leveraged its strong research foundation to consistently innovate its product offerings, ensuring Yakult remained at the forefront of the health and wellness trend. In the modern marketplace, Yakult's operations exemplify a successful case of strategic internationalization. By maintaining a robust distribution network across more than 40 countries, the company effectively taps into varying health consciousness trends across diverse cultures. Revenue is primarily derived from the sales of its probiotic beverages, which are produced through a time-honored fermentation process. Yakult has strengthened its market position through direct sales strategies, including the hallmark “Yakult Ladies,” who personally deliver products to customers, enhancing consumer engagement and fostering brand loyalty. Beyond beverages, Yakult has diversified its portfolio to include cosmetics and pharmaceuticals, though the probiotic drinks remain its core profit engine. This diversification not only draws on the company's microbiological expertise but also mitigates risk by reducing dependency on a single product line.

Intrinsic Value
3 300.3 JPY
Undervaluation 6%
Intrinsic Value
Price
Back to Top